|
Solvent |
mg/mL |
mM |
comments |
Solubility |
DMF |
30.0 |
135.59 |
|
DMF:PBS (pH 7.2) (1:1) |
0.5 |
2.26 |
|
DMSO |
54.7 |
247.07 |
|
Ethanol |
27.0 |
122.03 |
|
Note: There can be variations in solubility for the same chemical from different vendors or different batches from the same vendor. The following factors can affect the solubility of the same chemical: solvent used for crystallization, residual solvent content, polymorphism, salt versus free form, degree of hydration, solvent temperature. Please use the solubility data as a reference only. Warming and sonication will facilitate dissolving. Still have questions? Please contact our Technical Support scientists.
Preparing Stock Solutions
The following data is based on the
product
molecular weight
221.26
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Surmaitis RM, Nappe TM, Cook MD. Serotonin syndrome associated with
therapeutic metaxalone in a patient with cirrhosis. Am J Emerg Med. 2016
Feb;34(2):346.e5-6. doi: 10.1016/j.ajem.2015.06.043. Epub 2015 Jun 19. PubMed
PMID: 26159819.
2: Bishop-Freeman SC, Miller A, Hensel EM, Winecker RE. Postmortem Metaxalone
(Skelaxin®) Data from North Carolina. J Anal Toxicol. 2015 Oct;39(8):629-36. doi:
10.1093/jat/bkv066. PubMed PMID: 26378137.
3: Curtis B, Jenkins C, Wiens AL. A rare fatality attributed solely to
metaxalone. J Anal Toxicol. 2015 May;39(4):321-3. doi: 10.1093/jat/bkv008. Epub
2015 Feb 10. PubMed PMID: 25673649.
4: Martini DI, Nacca N, Haswell D, Cobb T, Hodgman M. Serotonin syndrome
following metaxalone overdose and therapeutic use of a selective serotonin
reuptake inhibitor. Clin Toxicol (Phila). 2015 Mar;53(3):185-7. doi:
10.3109/15563650.2015.1009993. Epub 2015 Feb 11. PubMed PMID: 25671244.
5: Bosak AR, Skolnik AB. Serotonin syndrome associated with metaxalone overdose.
J Med Toxicol. 2014 Dec;10(4):402-5. doi: 10.1007/s13181-014-0404-5. PubMed PMID:
24805103; PubMed Central PMCID: PMC4252289.
6: Rao RN, Farah H, Sahu PK, Janarthan M, Naidu ChG. Development and validation
of a stability-indicating assay including the isolation and characterization of
degradation products of metaxalone by LC-MS. Biomed Chromatogr. 2013
Dec;27(12):1733-40. doi: 10.1002/bmc.2987. Epub 2013 Jul 23. PubMed PMID:
23881540.
7: Goswami D, Saha A, Gurule S, Khuroo A, Monif T, Vats P. Metaxalone estimation
in biological matrix using high-throughput LC-MS/MS bioanalytical method. J
Chromatogr B Analyt Technol Biomed Life Sci. 2012 Aug 1;902:132-6. doi:
10.1016/j.jchromb.2012.05.034. Epub 2012 Jun 4. PubMed PMID: 22766230.
8: Trivedi RK, Patel MC. Development of a Stability-Indicating RP-UPLC Method for
Rapid Determination of Metaxalone and its Degradation Products in Solid Oral
Dosage Form. Sci Pharm. 2012 Jun;80(2):353-66. doi: 10.3797/scipharm.1112-08.
Epub 2012 Feb 21. PubMed PMID: 22896822; PubMed Central PMCID: PMC3383218.
9: Panda SS, Patanaik D, Ravi Kumar BV. New Stability-Indicating RP-HPLC Method
for Determination of Diclofenac Potassium and Metaxalone from their Combined
Dosage Form. Sci Pharm. 2012;80(1):127-37. doi: 10.3797/scipharm.1109-16. Epub
2011 Dec 5. PubMed PMID: 22396909; PubMed Central PMCID: PMC3293350.
10: Forrester MB. Pediatric metaxalone ingestions reported to Texas poison
control centers, 2000-2007. Pediatr Emerg Care. 2010 Jan;26(1):15-8. doi:
10.1097/PEC.0b013e3181c330dc. PubMed PMID: 20042913.
11: Forrester MB. Adult metaxalone ingestions reported to Texas poison control
centers, 2000-2006. Hum Exp Toxicol. 2010 Jan;29(1):55-62. doi:
10.1177/0960327108098150. Epub 2009 Nov 19. PubMed PMID: 19933254.
12: Zhang J, Fan X, Liu Y, Bo L, Liu X. Synthesis of poly(ethylene
glycol)-metaxalone conjugates and study of its controlled release in vitro. Int J
Pharm. 2007 Mar 6;332(1-2):125-31. Epub 2006 Sep 29. PubMed PMID: 17067768.
13: Nirogi RV, Kandikere VN, Shukla M, Mudigonda K, Shrivastava W, Datla PV.
Quantification of metaxalone in human plasma by liquid chromatography coupled to
tandem mass spectrometry. J Anal Toxicol. 2006 May;30(4):245-51. PubMed PMID:
16803662.
14: Poklis JL, Ropero-Miller JD, Garside D, Winecker RE. Metaxalone
(Skelaxin)-related death. J Anal Toxicol. 2004 Sep;28(6):537-41. PubMed PMID:
15516312.
15: KLEBER JW, NASH JF, LEE CC. QUALITATIVE AND QUANTITATIVE TESTS FOR
METAXALONE. J Pharm Sci. 1964 Dec;53:1522-3. PubMed PMID: 14255136.
16: FATHIE K. A SECOND LOOK AT A SKELETAL MUSCLE RELAXANT: A DOUBLE-BLIND STUDY
OF METAXALONE. Curr Ther Res Clin Exp. 1964 Nov;6:677-83. PubMed PMID: 14240758.
17: BROWN WE. EVALUATION OF METAXALONE (SKELAXIN). JAMA. 1964 Jan 25;187:291-2.
PubMed PMID: 14074467.
18: Moore KA, Levine B, Fowler D. A fatality involving metaxalone. Forensic Sci
Int. 2005 May 10;149(2-3):249-51. PubMed PMID: 15749367.
19: Toth PP, Urtis J. Commonly used muscle relaxant therapies for acute low back
pain: a review of carisoprodol, cyclobenzaprine hydrochloride, and metaxalone.
Clin Ther. 2004 Sep;26(9):1355-67. Review. PubMed PMID: 15530999.
20: Kuykendall JR, Rhodes RS. Auditory hallucinations elicited by combined
meclizine and metaxalone use at bedtime. Ann Pharmacother. 2004
Nov;38(11):1968-9. Epub 2004 Sep 28. PubMed PMID: 15454584.